These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19472156)

  • 1. [Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)].
    Calatayud-Noguera T; Astudillo-González A; Alvarez-Carriles JC; Temprano-Fernández T; Cortés-Velarde M; Oliva-Nacarino P
    Rev Neurol; 2009 Jun 1-15; 48(11):582-4. PubMed ID: 19472156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
    Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
    J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-pathological investigation of two patients with dementia with motor neuron disease].
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Kimura M; Eto K; Arai H; Ohbu S; Hatanaka D; Hino H; Fujisawa K
    Brain Nerve; 2007 Mar; 59(3):263-9. PubMed ID: 17370652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
    Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
    Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine for subcortical vascular dementia.
    Román GC
    Expert Rev Neurother; 2005 May; 5(3):309-13. PubMed ID: 15938663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE).
    Gauthier S; Juby A; Dalziel W; Réhel B; Schecter R;
    Curr Med Res Opin; 2010 May; 26(5):1149-60. PubMed ID: 20230208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathological basis of semantic dementia.
    Davies RR; Hodges JR; Kril JJ; Patterson K; Halliday GM; Xuereb JH
    Brain; 2005 Sep; 128(Pt 9):1984-95. PubMed ID: 16000337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rivastigmine: a review of its clinical effectiveness].
    Spiegel R
    Rev Neurol; 2002 Nov 1-15; 35(9):859-69. PubMed ID: 12436385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rivastigmine solution prescribing habits in patients with Alzheimer-type dementia in Spain (RIVASOL study)].
    González-Gutiérrez JL; Gobartt AL;
    Rev Neurol; 2007 Jun 16-30; 44(12):705-10. PubMed ID: 17583861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
    Frankfort SV; Appels BA; De Boer A; Tulner LR; Van Campen JP; Koks CH; Beijnen JH
    Int J Clin Pract; 2006 Jun; 60(6):646-54. PubMed ID: 16805746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the occupational disruptiveness scale of the neuropsychiatric inventory-nursing home version to measure the impact of rivastigmine on the disruptive behavior of nursing home residents with Alzheimer's disease.
    Hatoum HT; Lin SJ; Arcona S; Thomas SK; Koumaras B; Mirski D
    J Am Med Dir Assoc; 2005; 6(4):238-45. PubMed ID: 16005409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive and impulsive behaviors in Frontotemporal dementia and Alzheimer's disease.
    Grochmal-Bach B; Bidzan L; Pachalska M; Bidzan M; Łukaszewska B; Pufal A
    Med Sci Monit; 2009 May; 15(5):CR248-54. PubMed ID: 19396041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution and pathology of frontotemporal dementia.
    Kertesz A; McMonagle P; Blair M; Davidson W; Munoz DG
    Brain; 2005 Sep; 128(Pt 9):1996-2005. PubMed ID: 16033782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies.
    Kersaitis C; Halliday GM; Kril JJ
    Acta Neuropathol; 2004 Dec; 108(6):515-23. PubMed ID: 15368070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological heterogeneity of the precentral gyrus in Pick's disease: a study of 16 autopsy cases.
    Tsuchiya K; Piao YS; Oda T; Mochizuki A; Arima K; Hasegawa K; Haga C; Kakita A; Hori K; Tominaga I; Yagishita S; Akiyama H; Takahashi H
    Acta Neuropathol; 2006 Jul; 112(1):29-42. PubMed ID: 16609852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of frontotemporal lobar degeneration with ubiquitin-positive intraneuronal inclusions.
    Leel-Ossy L; Révész T; Almási K; Szucs I; Szabó E
    Ideggyogy Sz; 2007 Jul; 60(7-8):330-5. PubMed ID: 17713114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease.
    Lieberman AP; Trojanowski JQ; Lee VM; Balin BJ; Ding XS; Greenberg J; Morrison D; Reivich M; Grossman M
    Ann Neurol; 1998 Feb; 43(2):259-65. PubMed ID: 9485069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
    Mihara M; Hattori N; Abe K; Sakoda S; Sawada T
    Neuroreport; 2006 Mar; 17(4):413-6. PubMed ID: 16514368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome.
    Prasher VP; Fung N; Adams C
    Int J Geriatr Psychiatry; 2005 May; 20(5):496-7. PubMed ID: 15852458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.